No recent analyst price targets found for KYKOF.
Latest News for KYKOF

Kyowa Kirin stops development of skin condition treatment
Kyowa Kirin on Tuesday said it is discontinuing all ongoing trials of its experimental drug to treat skin conditions.
Reuters • Mar 3, 2026

Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends
Kyowa Kirin Co., Ltd. and Amgen Inc. (NASDAQ: AMGN) terminated on Friday the current rocatinlimab development and commercialization collaboration.
Benzinga • Jan 30, 2026
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for KYKOF.
Senate Trading
No Senate trades found for KYKOF.
U.S. House Trading
No House trades found for KYKOF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
